195 related articles for article (PubMed ID: 7056483)
1. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.
Hayasaka S; Okabe H; Takahashi J
Graefes Arch Clin Exp Ophthalmol; 1982; 218(1):9-13. PubMed ID: 7056483
[TBL] [Abstract][Full Text] [Related]
2. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Sasamoto Y; Ohno S; Matsuda H
Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada syndrome.
Ohno S; Char DH; Kimura SJ; O'Connor GR
Am J Ophthalmol; 1977 May; 83(5):735-40. PubMed ID: 868972
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
5. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome.
Rubsamen PE; Gass JD
Arch Ophthalmol; 1991 May; 109(5):682-7. PubMed ID: 2025171
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada syndrome. A case report.
Iversen TH; Sverrisson T
Acta Ophthalmol (Copenh); 1986 Apr; 64(2):235-8. PubMed ID: 3727967
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin therapy in Vogt Koyanagi Harada disease.
Wakefield D; McCluskey P; Reece G
Aust N Z J Ophthalmol; 1990 May; 18(2):137-42. PubMed ID: 2390240
[TBL] [Abstract][Full Text] [Related]
8. [Vogt-Koyanagi-Harada syndrome in children].
Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
[TBL] [Abstract][Full Text] [Related]
9. [Vogt Koyanagi Harada syndrome in children: diagnosis and management].
Benfdil N; Baha Ali T; Jellab B; Moutaouakil A
Bull Soc Belge Ophtalmol; 2010; (314):15-8. PubMed ID: 20480746
[TBL] [Abstract][Full Text] [Related]
10. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
[TBL] [Abstract][Full Text] [Related]
11. [Vogt-Koyanagi-Harada syndrome and cortisone].
Lugossy G
Bull Mem Soc Fr Ophtalmol; 1976; (87):44-6. PubMed ID: 1268419
[No Abstract] [Full Text] [Related]
12. Outcomes of patients with acute Vogt-Koyanagi-Harada disease treated with intravenous corticosteroid pulse followed by the slow tapering of oral corticosteroid therapy.
Fushitsu R; Ishibazawa A; Murono M; Kinouchi R
Int Ophthalmol; 2023 Feb; 43(2):431-440. PubMed ID: 35869402
[TBL] [Abstract][Full Text] [Related]
13. [Repeated pulse corticosteroid therapy in Vogt-Koyanagi-Harada disease. A case report].
Denoyer A; Le Lez ML; Arsène S; Pisella PJ
J Fr Ophtalmol; 2004 Apr; 27(4):404-8. PubMed ID: 15173651
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Caso F; Rigante D; Vitale A; Costa L; Bascherini V; Latronico E; Franceschini R; Cantarini L
Clin Rheumatol; 2015 Oct; 34(10):1817-20. PubMed ID: 25224382
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
16. [Vogt-Koyanagi-Harada syndrome: apropos of 2 cases].
Gabsi S; Hassoumi MH; Doss N; Mejri A; Othmani S; Bahri M
Tunis Med; 1989 Dec; 67(12):817-20. PubMed ID: 2623779
[No Abstract] [Full Text] [Related]
17. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
Lai TY; Chan RP; Chan CK; Lam DS
Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
[TBL] [Abstract][Full Text] [Related]
18. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Accorinti M; Saturno MC; Manni P
Ocul Immunol Inflamm; 2022 Jul; 30(5):1228-1233. PubMed ID: 35201950
[TBL] [Abstract][Full Text] [Related]
19. [Vogt-Koyanagi-Harada syndrome. Eight cases].
Alaoui FZ; Benamour S; El Kabli H; Amraoui A
Rev Med Interne; 2007 Apr; 28(4):250-4. PubMed ID: 17350144
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Spectrum and Outcome of Uveomeningitis: A Comprehensive Analysis of 110 Cases.
Hadjadj J; Gaube G; Groh M; Paule R; Salah S; Hoogewoud F; Blanche P; Mouthon L; Monnet D; Le Jeunne C; Brézin A; Terrier B
Ocul Immunol Inflamm; 2022 Aug; 30(6):1489-1494. PubMed ID: 33974484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
